Table 1.
Baseline Characteristics of Symptomatic Adult Patients Hospitalized with COVID-19
| History of Cancer | ||||
|---|---|---|---|---|
| Characteristic | No (N = 7330) | Yes (N = 892) | p | |
| Age (years) | 60.4 (17.4) | 70.6 (14.1) | < 0.001 | |
| Female Sex | 3231 (44.1) | 421 (47.2) | 0.077 | |
| BMI (kg/m2) | 30.6 (8.2) | 28.5 (7.7) | < 0.001 | |
| Race | White | 4522 (61.7) | 598 (67.0) | 0.009 |
| Black | 1736 (23.7) | 194 (21.8) | ||
| Asian/Pacific Islander | 469 (6.4) | 46 (5.2) | ||
| Other | 603 (8.2) | 54 (6.1) | ||
| Payment Source | Uninsured | 521 (7.1) | 22 (2.5) | < 0.001 |
| Private | 3946 (54.0) | 459 (51.6) | ||
| Medicare | 1267 (17.4) | 274 (30.7) | ||
| Medicaid | 1310 (17.9) | 124 (13.9) | ||
| Other | 259 (3.6) | 11 (1.2) | ||
| Atrial Fibrillation/Flutter | 626 (8.5) | 131 (14.7) | < 0.001 | |
| Diabetes Mellitus | 2722 (37.1) | 328 (36.8) | 0.832 | |
| Pulmonary Disease | 2522 (34.4) | 380 (42.6) | < 0.001 | |
| Chronic Kidney Disease | 928 (12.7) | 146 (16.4) | 0.002 | |
| Hypertension | 4287 (58.5) | 616 (69.1) | < 0.001 | |
| Smoking History | 461 (6.3) | 61 (6.8) | 0.53 | |
| Pulmonary Disease | 1305 (17.8) | 203 (22.8) | <0.001 | |
| Admission Symptoms | ||||
| Fever/Chills | 4823 (65.8) | 550 (61.7) | 0.014 | |
| Cough | 4867 (66.4) | 534 (59.9) | < 0.001 | |
| Shortness of Breath | 4552 (62.1) | 513 (57.5) | 0.008 | |
| Fatigue | 1845 (25.2) | 232 (26.0) | 0.59 | |
| Headache | 722 (9.9) | 49 (5.49) | < 0.001 | |
| Myalgia | 1580 (21.6) | 188 (21.1) | 0.74 | |
| Sore Throat | 506 (6.9) | 53 (5.94) | 0.28 | |
| Nasal Congestion | 375 (5.1) | 53 (5.94) | 0.30 | |
| Nausea/Vomiting/Diarrhea | 2066 (28.2) | 254 (28.5) | 0.86 | |
| Loss of Smell/Taste | 303 (4.1) | 44 (4.9) | 0.26 | |
| Confusion or AMS | 770 (10.5) | 145 (16.3) | < 0.001 | |
| COVID-19 Therapies | ||||
| Corticosteroid | 1547 (21.8) | 203 (24.7) | 0.056 | |
| Immunoglobulin | 53 (0.7) | 12 (1.4) | 0.05 | |
| Convalescent serum | 195 (2.7) | 27 (3.1) | 0.54 | |
| Ritonavir/Lopinavir | 76 (1.1) | 7 (0.9) | 0.60 | |
| Remdesivir | 565 (7.8) | 105 (11.9) | < 0.001 | |
| Tocilizumab | 523 (7.2) | 62 (7.0) | 0.82 | |
| Chemotherapy/biologics | 14 (0.19) | 124 (14.0) | < 0.001 | |
| History of CVD | 1544 (21.1) | 261 (29.3) | < 0.001 | |
Values are depicted as mean (standard deviation) or percentage (N) when appropriate.
BMI, Body Mass Index; CVD, Cardiovascular Disease; AMS, Altered Mental Status